Dr. Mark Christopher Pluym, MD

Dr. Pluym practices at Northeastern Vermont Regional Hospital in Saint Johnsbury, Vermont, part of Northeastern Vermont Regional Hospital.

Dr. Pluym's NPI, 1942597489, was assigned on July 5, 2011. Dr. Pluym holds Missouri license 2016028990.

Dr. Pluym's primary practice is Northeastern Vermont Regional Hospital, at 1315 Hospital Drive, Saint Johnsbury, VT 05819 in Caledonia County. The practice phone is (802) 748-7400.

Dr. Pluym's primary practice is Northeastern Vermont Regional Hospital in Saint Johnsbury, Vermont, part of Northeastern Vermont Regional Hospital. Dr. Pluym is also affiliated with Dartmouth Hitchcock Medical Center. The medical group on file is NVRH Cardiology. Dmand AI also links Dr. Pluym to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pluym practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Pluym's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Pluym is licensed in Missouri.

CMS data shows 1,288 Medicare services from Dr. Pluym across 14 procedure codes in 2024, for 416 Medicare patients. Medicare paid $56,445 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 416 Medicare patients who saw Dr. Pluym in 2024. The largest group is 65 to 74, with 179 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pluym's median patient age at 73, with 52% women.

In 2024, Dr. Pluym wrote 1,695 Medicare Part D claims for 304 patients. 38% of them were for generic drugs. CMS names the drug for 1,552 of them, across 30 drugs with 11 or more claims each, at $660,995 in total drug cost. In 2023, CMS named 1,425 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Pluym for performance year 2024, reported as part of a group. Dr. Pluym accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Pluym in 2015. Dr. Pluym has published most often in Hosp Pract (1995). Dr. Pluym's most frequent co-authors are Ashraf A. Gohar, MD, Gregory Howard Howell, MD and Asad Waseem Kabir, MD.

CMS Open Payments shows 480 general payments to Dr. Pluym from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,871.